Manufacturer of Controlled Substances; Notice of Registration, 8112 [05-3028]

Download as PDF 8112 Federal Register / Vol. 70, No. 32 / Thursday, February 17, 2005 / Notices Agreement may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), a fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $2.25 (25 cents per page reproduction cost), payable to the U.S. Treasury. Ronald Gluck, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 05–3013 Filed 2–16–05; 8:45 am] BILLING CODE 4410–15–M DEPARTMENT OF JUSTICE Notice of Lodging of Consent Decree Under the Comprehensive Environmental Response, Compensation, and Liability Act In accordance with 28 U.S.C. 50.7, notice is hereby given that on January 31, 2005, a proposed consent Decree in United States v. Thomasville Furniture Industries, Inc. et al., Civ. No. 6:05CV00001, was lodged with the United States District Court for the Western District of Virginia. The proposed consent decree would resolve the United States’ claims, on behalf of the Environmental Protection Agency (‘‘EPA’’), under Section 107(a) of the Comprehensive Environmental Response, Compensation, and Liability Act (‘‘CERCLA’’), 42 U.S.C. 9607(a), against Thomasville Furniture Industries, Inc., (‘‘Thomasville’’), Univar U.S.A., Inc. (‘‘Univar’’), and Buckingham County, a political subdivision of the Commonwealth of Virginia, to recover costs incurred by the United States in performing response actions at the Buckingham County Landfill Superfund Site (‘‘Site’’) in Dillwyn, Virginia as set forth in the terms of the decree. Both Thomasville and Univar are liable for the United States’ response costs under Section 107(a)(3) of CERCLA, 42 U.S.C. 9607(a)(3), because they, or their predecessors, arranged for disposal of CERCLA listed hazardous materials at the Site which led to a release of hazardous substances causing EPA to incur response costs. Buckingham County is liable for the United States’ response costs under Section 107(a)(1) of CERCLA, 42 U.S.C. 9607(a)(1), as the current owner and operator of the Site. VerDate jul<14>2003 14:41 Feb 16, 2005 Jkt 205001 Under the terms of the Consent Decree, Thomasville, Univar, and Buckingham County have agreed to pay $1,976,000 of EPA’s unreimbursed response costs of $2,052,458.26 at the Site. The United States has reserved its right to pursue an additional $171,688, incurred to implement a discrete drum removal action at the Site in 1999, from Buckingham County in a separate action. The proposed settlement addresses past costs only, and thus the Consent Decree reserves all parties’ rights with regard to future costs, except for the Defendants’ statute of limitations defenses. The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments relating to the Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States v. Thomasville Furniture Industries, Inc. et al., Civ. No. 6:05CV00001, D.J. Ref. 90–11–2–07971. The Consent Decree may be examined at the Office of the United States Attorney for the Western District of Virginia, 105 Franklin Road, SW., Suite 1, Roanoke, VA 24011. During the public comment period, the Consent Decree may also be examined on the following Department of Justice Web site, https://www.usdoj.gov/enrd/ open.html. A copy of the Consent Decree may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy of the Consent Decree from the Consent Decree Library, please enclose a check in the amount of $22.50 (90 pages at 25 cents per page reproduction cost) payable to the U.S. Treasury. Robert D. Brook, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 05–3011 Filed 2–16–05; 8:45 am] BILLING CODE 4410–15–M PO 00000 DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated October 18, 2004, and published in the Federal Register on October 25, 2004, (69 FR 62295), Cody Laboratories, Inc., 301 Yellowstone Avenue, Cody, Wyoming 82414, made application by renewal to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic class of controlled substances listed in Schedule II: Drug Amphetamine (1100) .................... Methamphetamine (1105) ............ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Cocaine (9041) ............................. Oxycodone (9143) ........................ Dihydromorphine (9145) ............... Hydromorphone (9150) ................ Diphenoxylate (9170) ................... Meperidine (9230) ........................ Oxymorphone (9652) ................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ Fmt 4703 Sfmt 4703 II II II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cody Laboratories, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cody Laboratories, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: February 11, 2005. William J. Walker, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 05–3028 Filed 2–16–05; 8:45 am] BILLING CODE 4410–09–P Frm 00057 Schedule E:\FR\FM\17FEN1.SGM 17FEN1

Agencies

[Federal Register Volume 70, Number 32 (Thursday, February 17, 2005)]
[Notices]
[Page 8112]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3028]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 18, 2004, and published in the Federal 
Register on October 25, 2004, (69 FR 62295), Cody Laboratories, Inc., 
301 Yellowstone Avenue, Cody, Wyoming 82414, made application by 
renewal to the Drug Enforcement Administration (DEA) for registration 
as a bulk manufacturer of the basic class of controlled substances 
listed in Schedule II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Amobarbital (2125).........................  II
Pentobarbital (2270).......................  II
Secobarbital (2315)........................  II
Cocaine (9041).............................  II
Oxycodone (9143)...........................  II
Dihydromorphine (9145).....................  II
Hydromorphone (9150).......................  II
Diphenoxylate (9170).......................  II
Meperidine (9230)..........................  II
Oxymorphone (9652).........................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cody Laboratories, Inc. to manufacture the listed basic classes of 
controlled substances is consistent with the public interest at this 
time. DEA has investigated Cody Laboratories, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: February 11, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-3028 Filed 2-16-05; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.